Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Ex Vivo Expansion of Phenotypic and Transcriptomic Chronic Myeloid Leukemia Stem Cells

Experimental Hematology(2022)10.1016/j.exphem.2022.09.001Source: DataRank Database

Ex Vivo Expansion of Phenotypic and Transcriptomic Chronic Myeloid Leukemia Stem Cells is a research paper published in Experimental Hematology (2022). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.18)OA: hybridTopics (34)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Valeriya Kuznetsova ORCID,Victoria Matkins,Alana Franceski ORCID,Mahmoud A. Bassal ORCID,Robert S. Welner ORCID

Live enrichment

PubMed:36115580 PMC:PMC12087282 OpenAlex:https://openalex.org/W4295941462

National Institutes of Health

Grant: 1PO1HL131477

National Institutes of Health

Grant: P30 AI027767-31

NIAID NIH HHS

Grant: P30 AI027767

NHLBI NIH HHS

Grant: P01 HL131477

NHLBI NIH HHS

Grant: R01 HL150078

NCI NIH HHS

Grant: P30 CA013148

FWCI

1.18

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.exphem.2022.09.001

publisherhttps://doi.org/10.1016/j.exphem.2022.09.001

publisherhttps://api.elsevier.com/content/article/PII:S0301472X22006968?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0301472X22006968?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36115580

Fields of Study

Chronic Myeloid Leukemia TreatmentsCytokine Signaling Pathways and InteractionsAcute Myeloid Leukemia ResearchMiceAnimalsTranscriptomeNeoplastic Stem CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTransforming Growth Factor beta

MeSH Terms

AnimalsNeoplastic Stem CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTransforming Growth Factor betaMiceTranscriptome

Keywords

Wnt signaling pathwayStem cellEx vivoHaematopoiesisCancer researchMyeloid leukemiaLeukemiaBiologyMyeloidPI3K/AKT/mTOR pathwayDrug developmentImmunologyIn vivoMedicinePharmacologyDrugSignal transductionCell biologyGenetics

Sustainable Development Goals

SDG 0: Good health and well-being

Ex Vivo Expansion of Phenotypic and Transcriptomic Chronic Myeloid Leukemia Stem Cells

FAIR Checklist

Authors (6)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)